311617
Determinants of long-acting reversible contraceptive use among women in Chad: Results from Supporting Access to Family Planning and Post-Abortion Care (SAFPAC) Initiative
METHODS: From July 2011 to December 2012, 8,179 FP clients’ records were collected from 18 SAFPAC Chad facilities. Epi Info 3 was used for data entry, and SPSS 19 was used for logistic regression analysis to identify determinants of women’s interest in LARC.
RESULTS: Among all FP clients, 6,800 (83%) selected a LARC method. Four of 6 determinants were significant. Catholic (OR = 2.7) and Protestant (OR = 3.9) women were much more likely to use LARC than Muslim women. Women aged 20 – 29 (OR = 0.69) and 30 – 39 (OR = 0.48) were less likely to use LARC than adolescent girls. Multiparous women (OR = 1.1) were more likely to use LARC. Women’s marital status and occupation were not significant.
IMPLICATIONS: Strong interest of using LARC exists in Catholic or Protestant women, multiparous women and, notably, those younger than 20 years. Programming should investigate and address lower acceptability of LARCs among Muslim women and older women using modern FP, and document reasons for success in reaching adolescent girls with LARCs.
Learning Areas:
Public health or related researchLearning Objectives:
Describe family planning choices and demographic characteristics of women in three districts of southern Chad.
Identify at least three factors that can influence women’s contraceptive choice.
Analyze possible reasons for higher uptake of long acting reversible contraceptives among adolescent girls and lower uptake of LARCs among older women and Muslim women.
Keyword(s): Family Planning, Reproductive Health
Qualified on the content I am responsible for because: I am a young public health professional who graduated with my MPH degree from Emory University in 2013. I have worked in SAFPAC Initiative for two years, and actively involved in program implementation and data management of the program. I am the primary person for compiling, cleaning and analyzing the data presented in the abstract, who is most familiar with the data and its implication.
Any relevant financial relationships? Yes
Name of Organization | Clinical/Research Area | Type of relationship |
---|---|---|
CARE USA | Sexual reproductive health | Employment (includes retainer) |
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.